(P1720) |
Metabolic effects of the adiponectin paralogs CTRP 1-10 |
|
L. Li, B. Siegler, R. Pan, B. Niemann, S. Rohrbach (Giessen) |
(P1721) |
Identification of distinct phases of reversible and irreversible statin-toxicity in a novel tissue engineered skeletal muscle model |
|
M. Tiburcy, P. Christalla, A. Markov, W.-H. Zimmermann (Göttingen) |
(P1722) |
Nebivolol increases Red Blood Cell NO-Formation without altering Red Blood Cell Deformability |
|
E. Rieckeheer, J. Reidenbach, B. Bölck, W. Bloch, R. H. G. Schwinger, K. Brixius (Köln, Weiden) |
(P1723) |
Natriuretic peptide receptor C is an endogenous inhibitor of angiotensin II/AT1 signaling pathway |
|
Y. Wang, B. Wiesner, T. Walther (Giessen, Berlin) |
(P1724) |
Inhibition of Angiotensin-Converting Enzyme (ACE) activation by the AT-2 receptor in vivo. |
|
T.-V. Dao Vu, O. Kocgirli, S. Agouri, M. Bas, T. Suvorava, G. Kojda (Düsseldorf, Muenchen) |
(P1725) |
Telmisartan reduces proinflammatory cytokine expression in human CD4-positive lymphocytes independent of the angiotensin type 1 receptor |
|
D. Walcher, D. Vasic, S. Lenz, W. Rottbauer, N. Marx (Ulm, Aachen) |
(P1726) |
Exercise NO-independently upregulates AT-2 receptor expression in-vivo. |
|
T.-V. Dao Vu, T. Suvorava, G. Kojda (Düsseldorf) |
(P1727) |
Myokardiales Fett in übergewichtigen/adipösen Frauen und seine Relation zu kardialen Funktionsparametern und Fitness |
|
W. Utz, S. Haufe, M. Pofahl, J. Traber, S. Engeli, F. C. Luft, M. Boschmann, J. Schulz-Menger, J. Jordan (Berlin, Hannover) |